Plant Comparison

Artichoke vs Purple coneflower

A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.

First plant
Second plant
Show:
Plant AArtichokeCynara scolymusAsteraceaeFull monograph →
Plant BPurple coneflowerEchinacea purpureaAsteraceaeFull monograph →

At a glance

Artichoke and Purple coneflower: both belong to the Asteraceae family.

ArtichokePurple coneflower
Constituents33
Pharmacological actions43
Indicated uses77
Safety notes22
Cited sources1519
Indicated uses
Only Artichoke
BloatingCardiovascular / heart healthDetox / cleansingHigh cholesterolIrritable bowel syndrome (IBS)IndigestionLiver support
Shared (0)
none
Only Purple coneflower
Arthritis / joint painCold & fluImmune supportInfection (general)Inflammation (general)Skin irritationWounds
Pharmacological actions
Only Artichoke
Choleretic / cholagogue (bile flow)Digestive aidHepatoprotective (liver support)Lipid-lowering
Shared (0)
none
Only Purple coneflower
Anti-inflammatoryAntimicrobialImmunomodulator / immune support

Key Constituents

Caffeoylquinic acids (chlorogenic acid and cynarin)[3, 6]

The principal choleretic, hepatoprotective and antioxidant constituents.

Chlorogenic acid
Flavonoids (luteolin glycosides)[3]

Antioxidant constituents of the leaf.

FlavonoidsGlycosidesLuteolin
Sesquiterpene lactones (cynaropicrin)[3]

The bitter principle that stimulates digestion.

Sesquiterpene lactonesSesquiterpenes
Alkamides[4]

Lipophilic alkamides are considered key immunomodulatory and anti-inflammatory constituents, particularly concentrated in the root.

Caffeic acid derivatives (echinacoside, cichoric acid)[4]

Antioxidant phenolic compounds contributing to the plant's immunomodulatory activity.

Caffeic acidPhenolic acids
Polysaccharides[4]

Water-soluble polysaccharides associated with immune-stimulating activity, particularly from the aerial parts.

Polysaccharides

Pharmacological Actions

Choleretic / cholagogue (bile flow)[3, 13]

Choleretic - stimulates bile flow to aid fat digestion

Digestive aid[3, 13]

Digestive aid for dyspeptic complaints - indigestion, bloating and fullness

Hepatoprotective (liver support)[1, 2, 3, 7, 11]

Hepatoprotective / liver support (protects liver cells and may aid their regeneration)

Lipid-lowering[3, 9, 10, 12, 14, 15]

Lipid-lowering - helps reduce cholesterol (an RCT showed lower total and LDL cholesterol and higher HDL; a Cochrane review judged the overall evidence promising but not yet convincing)

Anti-inflammatory[4, 11, 15, 16, 17]
Antimicrobial[7, 8, 10, 15, 16, 17]
Immunomodulator / immune support[4, 5, 6, 8, 9, 15, 16, 17]

Traditional & Indicated Uses

Bloating[3, 13]Limited · 3/10

Digestive aid for dyspeptic complaints - indigestion, bloating and fullness

Evidence: 3
Label: Bloating
Cardiovascular / heart health[3, 14, 15]Strong · 9/10

inferred from lipid-lowering action

Evidence: 9
Label: Cardiovascular / heart health
Detox / cleansing[3]Limited · 3/10

inferred from hepatoprotective action

Evidence: 3
Label: Detox / cleansing
High cholesterol[3, 9, 10, 12, 14, 15]Strong · 10/10

inferred from lipid-lowering action

Evidence: 10
Label: High cholesterol
Irritable bowel syndrome (IBS)[3]Limited · 3/10

Supports irritable bowel syndrome (IBS) symptoms

Evidence: 3
Label: Irritable bowel syndrome (IBS)
Indigestion[3, 13]Limited · 3/10

Digestive aid for dyspeptic complaints - indigestion, bloating and fullness

Evidence: 3
Label: Indigestion
Liver support[3, 11]Good · 8/10

Hepatoprotective / liver support (protects liver cells and may aid their regeneration)

Evidence: 8
Label: Liver support
Arthritis / joint pain[15, 16, 17]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Arthritis / joint pain
Cold & flu[15, 16, 17]Traditional · 1/10

inferred from immunomodulator action

Evidence: 1
Label: Cold & flu
Immune support[15, 16, 17]Traditional · 1/10
Evidence: 1
Label: Immune support
Infection (general)[15, 16, 17]Traditional · 1/10

inferred from antimicrobial action

Evidence: 1
Label: Infection (general)
Inflammation (general)[15, 16, 17]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Inflammation (general)
Skin irritation[15, 16, 17]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Skin irritation
Wounds[15, 16, 17]Traditional · 1/10

inferred from antimicrobial action

Evidence: 1
Label: Wounds

Safety, Cautions & Contraindications

Safety note[13]Caution

Because it stimulates bile flow, artichoke is contraindicated in bile-duct obstruction and should only be used under medical supervision if you have gallstones.

Safety note[13]Caution

As a member of the daisy family (Asteraceae), it can cause allergic reactions in sensitive people; use in pregnancy and breastfeeding is not recommended.

Safety note[15, 16, 17]Caution

Generally considered safe, but caution advised for those with autoimmune conditions. Not recommended for long-term use (more than 8 weeks continuously).

Safety note[15, 16, 17, 18]Caution

Duke (2002) rates echinacea as +++ — among the most thoroughly documented herbal immunostimulants. It notes experimental and clinical evidence for immunostimulant, antiviral, and anti-inflammatory activities. Multiple species have been studied (E. purpurea, E. angustifolia, E. pallida), and Duke emphasizes that species identification in commercial products is often unreliable. Commission E approves E. purpurea for supporting immune function during colds and flu. Dose: 900 mg standardized extract daily in acute use; use should be limited to 8 weeks continuous. Contraindicated in autoimmune diseases (MS, lupus, HIV/AIDS), tuberculosis, and with immunosuppressive drugs (cyclosporine) (Duke, 2002).

External Ids

Gbif: 3112361
Powo: urn:lsid:ipni.org:names:200902-1
Wikidata: Q134609
Gbif: 3150935
Powo: urn:lsid:ipni.org:names:1174497-2
Wikidata: Q272661

Botanical Description

Tall, thistle-like perennial herb with large, deeply lobed, silvery-green leaves, spiny in wild forms but usually spineless in cultivated globe artichoke. The plant produces a large, edible immature flower bud (the 'artichoke heart' of cuisine) which, left to mature, opens into a striking violet-blue thistle flower.[3]

Height: 1-2 m
Habit: Tall, robust, thistle-like perennial herb
Leaves: Large, deeply lobed, silvery-green, spiny in wild forms
Flowers: Large violet-blue thistle-type flower head, harvested immature as the edible artichoke bud
Stem: Stout, ridged, branching
Root: Deep, fleshy taproot
Fruit: Achene with a feathery pappus
Flowering Period: Summer, if buds are left unharvested

Robust perennial herb with a basal rosette of coarse, hairy, lance-shaped leaves and tall, sturdy flowering stems. Each stem bears a single large, daisy-like flower head with drooping (reflexed), rose-purple to pink ray florets surrounding a prominent, spiny, orange-brown central cone of disc florets.[4]

Height: 60-150 cm
Habit: Robust, clump-forming perennial herb
Leaves: Coarse, hairy, lance-shaped, in a basal rosette
Flowers: Large daisy-like heads with drooping rose-purple ray florets around a spiny orange-brown cone
Stem: Tall, sturdy, hairy, mostly unbranched
Root: Thick, fibrous, black-brown taproot
Fruit: Small four-angled achene
Flowering Period: June-September

Habitat

Native to the Mediterranean region; cultivated widely as a vegetable and medicinal crop in warm-temperate climates on rich, well-drained soil.[3]

Native to the tallgrass prairies, open woodland and dry meadows of central and eastern North America; widely cultivated worldwide as a garden and medicinal plant.[4]

Harvesting

For medicinal use, the leaves are picked before flowering, when caffeoylquinic acid (chlorogenic acid/cynarin) content is highest, and dried; the edible flower bud is separately harvested young, before the flower opens.[3]

Parts: Leaf
Season: Before flowering

The flower heads are picked as they open, in summer; the root is dug in autumn from plants at least two to three years old, when its content of bioactive alkamides and caffeic acid derivatives is highest, then cleaned and dried.[4]

Parts: Flower, Root
Season: Flower in summer; root in autumn from mature plants

Traditional Uses

Artichoke leaf has a long Mediterranean folk history as a bitter digestive and liver remedy, used to stimulate bile flow and ease dyspeptic complaints such as indigestion, bloating and fullness, and as a traditional hepatoprotective 'liver tonic'; modern standardised leaf extracts are also studied for supporting healthy cholesterol levels.[3]

Echinacea root was widely used by Native American peoples as a remedy for infections, wounds, snakebite and toothache, and entered nineteenth-century Eclectic medicine as a broad anti-infective. It remains best known today, in standardised aerial-part or root extracts, as a supportive remedy for preventing and shortening the common cold and supporting immune function.[1, 4]

Preparations

Standardised extract[3]

Dried leaf extract standardised to caffeoylquinic acid (chlorogenic acid/cynarin) content, taken as capsules or tablets for digestive and lipid support.

Standardised extract[1]

Fresh-pressed juice or standardised extract of the aerial parts or root, taken as tablets, drops or capsules at the first sign of a cold; the best-studied clinical form.

Dosage

Standardised extract[3]

Clinical studies commonly use extracts providing around 300-640 mg dried leaf extract, up to three times daily. Educational reference only, not a prescription.

Standardised extract[1]

Clinical trials for the common cold commonly use around 300-900 mg of standardised extract daily, started at the first sign of symptoms and continued for up to 7-10 days; continuous use beyond about 8 weeks is not recommended. Educational reference only, not a prescription.

References

REF-1634, REF-1635, REF-0461, REF-1636, REF-1637, REF-1638, REF-1639, REF-1640, REF-2566, REF-2567, REF-2568, REF-2569
REF-0797, REF-0798, REF-0799, REF-2011, REF-2012, REF-2013, REF-2014, REF-2015, REF-2016, REF-2017, REF-2018, REF-2019, REF-2020, REF-2021

Lookalikes Review

Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07
Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07

Drug Class Interactions

Not documented

Safety note[19]Caution
Drug Class: immunosuppressants
Mechanism: Echinacea can both stimulate immune activity and alter CYP3A/CYP1A2 enzymes, so it may reduce the effect or change the blood levels of immunosuppressant drugs such as ciclosporin and tacrolimus; use only under medical supervision after a transplant or with autoimmune therapy.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03

References & Sources

  1. Porro, C., Benameur, T., Cianciulli, A., Vacca, M. and others (2024) 'Functional and Therapeutic Potential of Cynara scolymus in Health Benefits', Nutrients, 16(6), pp. 872. doi:10.3390/nu16060872 Meta-analysis / review
    https://doi.org/10.3390/nu16060872
  2. Salekzamani, S., Ebrahimi-Mameghani, M. and Rezazadeh, K (2019) 'The antioxidant activity of artichoke (Cynara scolymus): A systematic review and meta-analysis of animal studies', Phytotherapy Research, 33(1), pp. 55-71. doi:10.1002/ptr.6213 Meta-analysis / review
    https://doi.org/10.1002/ptr.6213
  3. Ben Salem, M., Affes, H., Ksouda, K., Dhouibi, R., Sahnoun, Z., Hammami, S. and Zeghal, K.M (2015) 'Pharmacological Studies of Artichoke Leaf Extract and Their Health Benefits', Plant Foods for Human Nutrition. doi:10.1007/s11130-015-0503-8 Clinical study
    https://doi.org/10.1007/s11130-015-0503-8
  4. Gotardo, A.T., Mattos, M.I.S., Hueza, I.M. and Gorniak, S.L (2019) 'The effect of Cynara scolymus (artichoke) on maternal reproductive outcomes and fetal development in rats', Regulatory Toxicology and Pharmacology, 102, pp. 74-78. doi:10.1016/j.yrtph.2019.01.004 Preclinical
    https://doi.org/10.1016/j.yrtph.2019.01.004
  5. Ben Salem, M., Affes, H., Dhouibi, R., Charfi, S. and others (2019) 'Preventive effect of Artichoke (Cynara scolymus L.) in kidney dysfunction against high fat-diet induced obesity in rats', Archives of Physiology and Biochemistry, 128(3), pp. 586-592. doi:10.1080/13813455.2019.1703755 Preclinical
    https://doi.org/10.1080/13813455.2019.1703755
  6. Dominguez-Fernandez, M., Ludwig, I.A., De Pena, M.P. and Cid, C (2021) 'Bioaccessibility of Tudela artichoke (Cynara scolymus cv. Blanca de Tudela) (poly)phenols: the effects of heat treatment, simulated gastrointestinal digestion and human colonic microbiota', Food & Function, 12(5), pp. 1996-2011. doi:10.1039/d0fo03119d Preclinical
    https://doi.org/10.1039/d0fo03119d
  7. Ahmadi, A., Heidarian, E. and Ghatreh-Samani, K (2019) 'Modulatory effects of artichoke (Cynara scolymus L.) leaf extract against oxidative stress and hepatic TNF-alpha gene expression in acute diazinon-induced liver injury in rats', Journal of Basic and Clinical Physiology and Pharmacology, 30(5), pp. 20180180. doi:10.1515/jbcpp-2018-0180 Preclinical
    https://doi.org/10.1515/jbcpp-2018-0180
  8. Grazina, L., Batista, A., Amaral, J.S., Costa, J. and Mafra, I (2021) 'Botanical authentication of globe artichoke-containing foods: Differentiation of Cynara scolymus by a novel HRM approach', Food Chemistry, 366, pp. 130621. doi:10.1016/j.foodchem.2021.130621 Preclinical
    https://doi.org/10.1016/j.foodchem.2021.130621
  9. Sahebkar, A., Pirro, M., Banach, M., Mikhailidis, D.P., Atkin, S.L. and Cicero, A.F.G (2017) 'Lipid-lowering activity of artichoke extracts: A systematic review and meta-analysis', Critical Reviews in Food Science and Nutrition, 58(15), pp. 2549-2556. doi:10.1080/10408398.2017.1332572 Meta-analysis / review
    https://doi.org/10.1080/10408398.2017.1332572
  10. Shahinfar, H., Bazshahi, E., Amini, M.R., Payandeh, N., Pourreza, S., Noruzi, Z. and Shab-Bidar, S (2021) 'Effects of artichoke leaf extract supplementation or artichoke juice consumption on lipid profile: A systematic review and dose-response meta-analysis of randomized controlled trials', Phytotherapy Research, 35(12), pp. 6607-6623. doi:10.1002/ptr.7247 Meta-analysis / review
    https://doi.org/10.1002/ptr.7247
  11. Kamel, A.M. and Farag, M.A (2022) 'Therapeutic Potential of Artichoke in the Treatment of Fatty Liver: A Systematic Review and Meta-Analysis', Journal of Medicinal Food, 25(10), pp. 931-942. doi:10.1089/jmf.2022.0025 Meta-analysis / review
    https://doi.org/10.1089/jmf.2022.0025
  12. Santos, H.O., Bueno, A.A. and Mota, J.F (2018) 'The effect of artichoke on lipid profile: A review of possible mechanisms of action', Pharmacological Research, 137, pp. 170-178. doi:10.1016/j.phrs.2018.10.007 Meta-analysis / review
    https://doi.org/10.1016/j.phrs.2018.10.007
  13. European Medicines Agency (HMPC) (n.d.) 'European Union herbal monograph on Cynara cardunculus L. (syn. Cynara scolymus L.), folium (Cynarae folium)'. Available at: https://www.ema.europa.eu/en/medicines/herbal/cynarae-folium Traditional / reference
    https://www.ema.europa.eu/en/medicines/herbal/cynarae-folium
  14. Wider, B., Pittler, M.H., Thompson-Coon, J. and Ernst, E (2013) 'Artichoke leaf extract for treating hypercholesterolaemia', Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD003335.pub3 Meta-analysis / review
    https://doi.org/10.1002/14651858.CD003335.pub3
  15. Rondanelli, M., Giacosa, A., Opizzi, A., Faliva, M.A., Sala, P. and others (2012) 'Beneficial effects of artichoke leaf extract supplementation on increasing HDL-cholesterol in subjects with primary mild hypercholesterolaemia: a double-blind, randomized, placebo-controlled trial', International Journal of Food Sciences and Nutrition, 64(1), pp. 7--15. doi:10.3109/09637486.2012.700920 Randomized trial
    https://doi.org/10.3109/09637486.2012.700920
  1. Karsch-Völk, M., Barrett, B., Kiefer, D., Bauer, R. et al (2014) 'Echinacea for preventing and treating the common cold', Cochrane Database of Systematic Reviews, 2(2), pp. CD000530. doi:10.1002/14651858.CD000530.pub3 Meta-analysis / review
    https://doi.org/10.1002/14651858.CD000530.pub3
  2. Kamin, W., Seifert, G., Zwiauer, K., Bonhoeffer, J. et al (2025) 'Phytotherapy for acute respiratory tract infections in children: a systematically conducted, comprehensive review', Frontiers in Pediatrics, 13, pp. 1423250. doi:10.3389/fped.2025.1423250 Meta-analysis / review
    https://doi.org/10.3389/fped.2025.1423250
  3. Fashner, J., Ericson, K. and Werner, S (2012) 'Treatment of the common cold in children and adults', American Family Physician, 86(2), pp. 153-159. Available at: https://pubmed.ncbi.nlm.nih.gov/22962927/ Traditional / reference
    https://pubmed.ncbi.nlm.nih.gov/22962927/
  4. Manayi, A., Vazirian, M. and Saeidnia, S (2015) 'Echinacea purpurea: Pharmacology, phytochemistry and analysis methods', Pharmacognosy Reviews, 9(17), pp. 63-72. doi:10.4103/0973-7847.156353 Meta-analysis / review
    https://doi.org/10.4103/0973-7847.156353
  5. Burlou-Nagy, C., Banica, F., Jurca, T., Vicas, L.G., Marian, E., Muresan, M.E., Bacskay, I., Kiss, R., Feher, P. and Pallag, A (2022) 'Echinacea purpurea (L.) Moench: Biological and Pharmacological Properties. A Review', Plants, 11(9), pp. 1244. doi:10.3390/plants11091244 Meta-analysis / review
    https://doi.org/10.3390/plants11091244
  6. Hall, H., Fahlman, M.M. and Engels, H.J (2007) 'Echinacea purpurea and mucosal immunity', International Journal of Sports Medicine, 28(9), pp. 792-797. doi:10.1055/s-2007-964895 Randomized trial
    https://doi.org/10.1055/s-2007-964895
  7. Ross, S.M (2016) 'Echinacea purpurea: A Proprietary Extract of Echinacea purpurea Is Shown to be Safe and Effective in the Prevention of the Common Cold', Holistic Nursing Practice, 30(1), pp. 54-57. doi:10.1097/HNP.0000000000000130 Meta-analysis / review
    https://doi.org/10.1097/HNP.0000000000000130
  8. Hudson, J.B (2011) 'Applications of the phytomedicine Echinacea purpurea (Purple Coneflower) in infectious diseases', Journal of Biomedicine & Biotechnology, 2012, pp. 769896. doi:10.1155/2012/769896 Meta-analysis / review
    https://doi.org/10.1155/2012/769896
  9. Mishima, S., Saito, K., Maruyama, H., Inoue, M., Yamashita, T., Ishida, T. and Gu, Y (2004) 'Antioxidant and immuno-enhancing effects of Echinacea purpurea', Biological & Pharmaceutical Bulletin, 27(7), pp. 1004-1009. doi:10.1248/bpb.27.1004 Preclinical
    https://doi.org/10.1248/bpb.27.1004
  10. Saunders, P.R., Smith, F. and Schusky, R.W (2007) 'Echinacea purpurea L. in children: safety, tolerability, compliance, and clinical effectiveness in upper respiratory tract infections', Canadian Journal of Physiology and Pharmacology, 85(11), pp. 1195-1199. doi:10.1139/Y07-103 Clinical study
    https://doi.org/10.1139/Y07-103
  11. Micheli, L., Maggini, V., Ciampi, C., Gallo, E., Bogani, P., Fani, R., Pistelli, L., Ghelardini, C., Di Cesare Mannelli, L., De Leo, M. and Firenzuoli, F (2022) 'Echinacea purpurea against neuropathic pain: Alkamides versus polyphenols efficacy', Phytotherapy Research, 37(5), pp. 1911-1923. doi:10.1002/ptr.7709 Preclinical
    https://doi.org/10.1002/ptr.7709
  12. Gholami, M., Amri, J., Pazhoohan, S. and Sadegh, M (2021) 'Anticonvulsive and anti-epileptogenesis effects of Echinacea purpurea root extract, an involvement of CB2 receptor', Journal of Complementary & Integrative Medicine, 19(4), pp. 879-886. doi:10.1515/jcim-2020-0219 Preclinical
    https://doi.org/10.1515/jcim-2020-0219
  13. Awortwe, C., Bruckmueller, H., Kaehler, M. and Cascorbi, I (2021) 'Interaction of Phytocompounds of Echinacea purpurea with ABCB1 and ABCG2 Efflux Transporters', Molecular Pharmaceutics, 18(4), pp. 1622-1633. doi:10.1021/acs.molpharmaceut.0c01075 Preclinical
    https://doi.org/10.1021/acs.molpharmaceut.0c01075
  14. Perry, N.B., van Klink, J.W., Burgess, E.J. and Parmenter, G.A (1997) 'Alkamide levels in Echinacea purpurea: a rapid analytical method revealing differences among roots, rhizomes, stems, leaves and flowers', Planta Medica, 63(1), pp. 58-62. doi:10.1055/s-2006-957605 Preclinical
    https://doi.org/10.1055/s-2006-957605
  15. Linde, K., Barrett, B., Wölkart, K., Bauer, R. and Melchart, D (2006) 'Echinacea for preventing and treating the common cold'. Traditional / reference
    https://scholar.google.com/scholar?q=Echinacea%20for%20preventing%20and%20treating%20the%20common%20cold
  16. Sharma, M., Schoop, R., Suter, A. and Schoop, W (2010) 'The possibility of prophylactic treatment of streptococcal pharyngotonsillitis with a standardized Echinacea preparation', 29(8), pp. 1025--1035. Traditional / reference
    https://scholar.google.com/scholar?q=The%20possibility%20of%20prophylactic%20treatment%20of%20streptococcal%20pharyngotonsillitis%20with%20a%20standardized%20Echinacea%20preparation
  17. World Health Organization (1999) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
    https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants
  18. Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
    https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
  19. Gorski, J.C., Huang, S.M., Pinto, A., Hamman, M.A., Hilligoss, J.K., Zaheer, N.A., Desai, M., Miller, M. and Hall, S.D (2004) 'The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo', Clinical Pharmacology and Therapeutics, 75(1), pp. 89-100. doi:10.1016/j.clpt.2003.09.013 Clinical study
    https://doi.org/10.1016/j.clpt.2003.09.013

Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.